Medication info
Aklalon Tablet 375 mg (Amoxicillin-Clavulanate Potassium (2:1))

Aklalon Tablet 375 mg (Amoxicillin-Clavulanate Potassium (2:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mgDilute Potassium Clavulanate›215.52mg
Manufacturer / importer
McNulty Pharmaceuticals Co., Ltd.
Appearance
White or almost white oval film-coated tablet
Packaging
100 tablets/PTP (10 tablets x 10)
Approval status
Active

MFDS item code 201906090 · Approved 2019.08.27 · Insurance code 641502470

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally three times daily, every 8 hours; for severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Creatinine clearance 10 ~ 30 mL/min: Administer an amount equivalent to 250 ~ 500 mg of amoxicillin orally every 12 hours. 10 mL/min or less: Administer an amount equivalent to 250 mg of amoxicillin every 24 hours, ensuring that the dose is not exceeded. However, for dental infections, administer an amount equivalent to 250 mg of amoxicillin three times daily for 5 days.
Child dose
Children aged 12 years and older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally three times daily, every 8 hours; for severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
McNulty Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is effective against various bacteria including Staphylococcus aureus, Escherichia coli, and Streptococcus pneumoniae, and is used for respiratory infections such as acute and chronic bronchitis, pneumonia, and otitis media. It is also effective for urinary tract infections, including cystitis, urethritis, and pyelonephritis, as well as genital infections such as gonorrhea and pelvic infections. It is used for skin and soft tissue infections, abscesses, wound infections, and osteomyelitis. It is broadly used for various bacterial infections, including dental infections.

How to take

Adult dose

Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally three times daily, every 8 hours; for severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Creatinine clearance 10 ~ 30 mL/min: Administer an amount equivalent to 250 ~ 500 mg of amoxicillin orally every 12 hours. 10 mL/min or less: Administer an amount equivalent to 250 mg of amoxicillin every 24 hours, ensuring that the dose is not exceeded. However, for dental infections, administer an amount equivalent to 250 mg of amoxicillin three times daily for 5 days.

Child dose

Children aged 12 years and older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally three times daily, every 8 hours; for severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg per dose. Children: Reduce the dose in the same manner.

Precautions

This medication should not be used in patients with hypersensitivity to specific ingredients or beta-lactam antibiotics. Caution is necessary for patients with viral infections such as infectious mononucleosis or lymphocytic leukemia, as the risk of rash may increase. Patients with a history of liver dysfunction or jaundice should be careful as this medication may worsen liver function. Patients with liver impairment should use this medication with caution as liver function may deteriorate further. Patients with moderate to severe renal impairment may experience increased plasma concentration of the drug, requiring adjustment of dosing intervals. Patients with allergic constitutions or those with bronchial asthma, urticaria, etc., should be cautious as allergy reactions may occur when taking this medication. Elderly patients or those in poor general condition, and patients who have difficulty with oral intake may be at risk of vitamin K deficiency, and caution is needed. Patients with gastrointestinal diseases such as vomiting or diarrhea may insufficiently absorb the medication and should use it cautiously. Gastrointestinal adverse reactions such as diarrhea, vomiting, and abdominal pain may occur, and serious conditions like pseudomembranous colitis can develop; if symptoms appear, discontinue the medication immediately and consult a doctor. Liver dysfunction or jaundice symptoms may occur rarely, particularly in elderly and male patients, so regular liver function tests are necessary. Skin rashes, itching, and severe skin reactions such as Stevens-Johnson syndrome can occur; if these symptoms appear, discontinue medication immediately. Blood tests may show leukopenia, thrombocytopenia, etc., rarely, so testing is needed for any abnormal symptoms. Central nervous system adverse symptoms such as drowsiness, headache, and seizures may occur, especially in patients with decreased kidney function. Acute renal failure or interstitial nephritis may develop, so renal function should be monitored regularly. Bleeding tendencies due to vitamin K deficiency may arise, so any bleeding symptoms should be reported to medical personnel immediately. This medication may interact with other drugs; especially if the patient is taking anticoagulants, anti-inflammatory drugs, oral contraceptives, or immunosuppressants, they should consult a physician or pharmacist. Women who are pregnant or may become pregnant should preferably avoid using this medication during the first three months of pregnancy, and caution is needed during breastfeeding as side effects may appear in the baby. Children under 12 years of age or weighing less than 40 kg have limited experience of use, so it is not recommended for them. Elderly patients may have an increased risk of side effects due to diminished physiological function, so dosage and intervals should be adjusted cautiously while monitoring their condition. While taking this medication, it is important to regularly check liver function, kidney function, and blood test results to take prompt action if abnormalities occur. In case of overdose, gastrointestinal symptoms, renal failure, seizures, allergic reactions, etc., may occur, so if suspected, visit a medical institution immediately for appropriate treatment. Store the medication in a sealed container to avoid moisture and keep it in a dry place below 25 degrees Celsius to maintain its efficacy.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, soft stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis with bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucous membrane pemphigoid, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized pustular eruption, drug reaction with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, respiratory distress with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal irritation, increased discharge, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, convulsions, antiparkinsonism, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B deficiency symptoms, linear IgA disease, dysgeusia, lethargy, dermatitis, oral edema, stomach pain, fluid and electrolyte imbalance, hyperactivity, drowsiness, decreased urine output, interstitial seizures, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent moisture, in a dry place below 25 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White or almost white oval film-coated tablet

Package unit

100 tablets/PTP (10 tablets x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.